Comparative Proteomic Analysis of Plasma from Hypertensive Patients after Valsartan Treatment
BACKGROUND: This study was designed to investigate the plasma proteomic profile of untreated essential hypertensive (EH) patients and EH patients treated with angiotensin Ⅱ type 1 receptor antagonist (AT1RA) valsartan, which may lead to better understanding of potential pathogenic mechanisms, early diagnosis,prevention and treatment of hypertensive left ventricle hyperplasia (LVH).
Z.G.Wang X.Y.Peng M.Li B.Zhang L.J.Wang J.L.Liu Y.Liu Y.X.Wei S.J.Wen
Beijing Institute of Heart, Lung,Blood Vessel Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing, China
国内会议
苏州
英文
346-346
2015-09-11(万方平台首次上网日期,不代表论文的发表时间)